We observed that activation of CD4+ T cells via the anti-CD3/CD28 pathway shifted the domination of transcription factors expression towards Th1 (Table S1), whereas the presence of HD/ASCs switched it from Th1 to Th2 (Figure 1A). The gene discussed is CD4; the disease is Huntington disease.